Scientists have developed a method to enhance the ability of T cells to target prostate cancer cells. This approach involves modifying T cell receptors to create stronger bonds with cancer cells, allowing the immune cells to stick to them for a longer period. The technique is being explored as a potential improvement to targeted cancer therapy.